The secondary Müllerian system, field effect, BRCA, and tubal fimbria: our evolving understanding of the origin of tubo-ovarian high-grade serous carcinoma and why assignment of primary site matters

Pathology

Volumn 47, Issue 5, 2015, Pages 423-431

  Singh, Naveena ^a   Gilks, C Blake ^a   Wilkinson, Nafisa ^a   McCluggage, W Glenn ^a  

^a BARTS HEALTH NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ANIMAL; CARCINOMA IN SITU; CYSTADENOCARCINOMA, SEROUS; EPITHELIUM; FALLOPIAN TUBE; FEMALE; HUMAN; METABOLISM; OVARY TUMOR; PATHOLOGY;

ANIMALS; CARCINOMA IN SITU; CYSTADENOCARCINOMA, SEROUS; EPITHELIUM; FALLOPIAN TUBES; FEMALE; HUMANS; OVARIAN NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84979847647     PISSN: None     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0000000000000291     Document Type: Article

References (0)